user

Effect of APOE genotype on progression of regional cerebral atrophy and cognitive decline in patients with Alzheimer's disease

被引：0
|
作者：
Hampel, H
Pruessner, J
Buerger, K
Faltraco, F
Moeller, HJ
Teipel, SJ
Leinsinger, G
Evans, AC
机构：
[1] McConnell Brain Imaging Ctr, Montreal, PQ, Canada
[2] LMU, Dept Radiol, Munich, Bavaria, Germany
[3] LMU, Dept Psychiat, Munich, Bavaria, Germany
来源：
NEUROBIOLOGY OF AGING | 2002年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
1744
引用
收藏
页码：S479 / S480
页数：2
相关论文
共 50 条
  • [41] Progression of atrophy in Alzheimer's disease
    Killiany, Ronald
    [J]. LANCET NEUROLOGY, 2006, 5 (10): : 805 - 806
  • [42] Effects of statins and fibrates on progression of cognitive decline in Alzheimer's disease
    Masse, I
    Bordet, R
    Deplanque, D
    Al Khedr, A
    Libersa, C
    Pasquier, F
    [J]. NEUROLOGY, 2004, 62 (07) : A175 - A176
  • [43] Slowing the progression of cognitive decline in alzheimer’s disease using mifepristone
    Joseph K. Belanoff
    Jennifer Jurik
    Lindsey D. Schatzberg
    Charles DeBattista
    Alan F. Schatzberg
    [J]. Journal of Molecular Neuroscience, 2002, 19 : 201 - 206
  • [44] Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone
    Belanoff, JK
    Jurik, J
    Schatzberg, LD
    DeBattista, C
    Schatzberg, AF
    [J]. JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 19 (1-2) : 201 - 206
  • [45] The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer's Prevention Registry
    Lee, A. K. W.
    Collier, M. K.
    Thompson, L. I.
    Popescu, D.
    Arthur, E.
    Correia, S.
    Salloway, S. P.
    Alber, J.
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2023, 10 (02): : 152 - 161
  • [46] The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer’s Prevention Registry
    Athene K. W. Lee
    M. K. Collier
    L. I. Thompson
    D. Popescu
    E. Arthur
    S. Correia
    S. P. Salloway
    J. Alber
    [J]. The Journal of Prevention of Alzheimer's Disease, 2023, 10 : 152 - 161
  • [47] Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging
    Burns, Jeffrey M.
    Honea, Robyn A.
    Vidoni, Eric D.
    Hutfles, Lewis J.
    Brooks, William M.
    Swerdlow, Russell H.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03): : 333 - 339
  • [48] Understanding the effect of cognitive/brain reserve and depression on regional atrophy in early Alzheimer's disease
    Capogna, Elettra
    Manca, Riccardo
    De Marco, Matteo
    Hall, Anette
    Soininen, Hilkka
    Venneri, Annalena
    [J]. POSTGRADUATE MEDICINE, 2019, 131 (07) : 533 - 538
  • [49] Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study
    Falsetti, Lorenzo
    Viticchi, Giovanna
    Buratti, Laura
    Grigioni, Francesco
    Capucci, Alessandro
    Silvestrini, Mauro
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (02) : 713 - 725
  • [50] APOE genotype:: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease
    Aerssens, J
    Raeymaekers, P
    Lilienfeld, S
    Geerts, H
    Konings, F
    Parys, W
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (02) : 69 - 77
12345